Journal of Cancer Therapy
Vol.4 No.3(2013), Paper ID 31947, 10
pages
DOI:10.4236/jct.2013.43095
Lenalidomide and Arsenic Trioxide Have Independent Non-Interfering Effects When Used in Combination on Myeloma Cell Lines in Vitro
Huaquan Wang, Xianghong Chen, Erika A. Eksioglu, Junmin Zhou, Nicole R. Fortenbery, Julie Djeu, Alan List, Sheng Wei
Hematology Department, General Hospital, Tianjin Medical University, Tianjin, China
Immunology Program and Malignant Hematology Program, Moffitt Cancer Center and Research Institute, Tampa, USA.
Immunology Program and Malignant Hematology Program, Moffitt Cancer Center and Research Institute, Tampa, USA.
Immunology Program and Malignant Hematology Program, Moffitt Cancer Center and Research Institute, Tampa, USA.
Immunology Program and Malignant Hematology Program, Moffitt Cancer Center and Research Institute, Tampa, USA.
Immunology Program and Malignant Hematology Program, Moffitt Cancer Center and Research Institute, Tampa, USA.
Immunology Program and Malignant Hematology Program, Moffitt Cancer Center and Research Institute, Tampa, USA.
Immunology Program and Malignant Hematology Program, Moffitt Cancer Center and Research Institute, Tampa, USA.
Copyright © 2013 Huaquan Wang, Xianghong Chen, Erika A. Eksioglu, Junmin Zhou, Nicole R. Fortenbery, Julie Djeu, Alan List, Sheng Wei et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
H. Wang, X. Chen, E. Eksioglu, J. Zhou, N. Fortenbery, J. Djeu, A. List and S. Wei, "Lenalidomide and Arsenic Trioxide Have Independent Non-Interfering Effects When Used in Combination on Myeloma Cell Lines in
Vitro,"
Journal of Cancer Therapy, Vol. 4 No. 3, 2013, pp. 787-796. doi:
10.4236/jct.2013.43095.